Abstract
This study was designed to evaluate and compare the inhibitory property of extracts of Andrographis paniculata leaves [methanolic (AP1), hydroalcoholic (AP2), successive water (AP3)] and non-leaves [methanolic (AP4), hydroalcoholic (AP5), successive water (AP6)] towards inflammatory mediators (NO, IL-1 beta, IL-6, TNF alpha, PGE2, TXB2 and LTB4). Stimulant induced J774A.1 murine macrophages and HL-60 promyelocytic leukemic cells were used to study the inhibitory potential of extracts of A. paniculata on inflammatory mediators. Results revealed that AP1 and AP4 exhibited inhibitory effect on all the inflammatory mediators excluding PGE2 and TNF-alpha. AP2 and AP5 exhibited inhibitory effect towards IL-1 beta, TXB2 and did not show inhibitory effect towards other mediators. However, AP3 and AP6 failed to show inhibitory activity against any of the inflammatory mediators at the tested concentrations. Further, we observed that the magnitude of inhibitory effect displayed by A. paniculata extracts depends on the andrographolide content, although, it does not appear to influence the inhibitory effect towards LTB4 production.
Keywords: Andrographis paniculata, leaves, non-leaves, inflammatory mediators (NO, IL-1 beta, IL-6, LTB4, PGE2, TNF-alpha and TXB2)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:In Vitro Comparative Evaluation of Non-Leaves and Leaves Extracts of Andrographis paniculata on Modulation of Inflammatory Mediators
Volume: 11 Issue: 2
Author(s): C. V. Chandrasekaran, B. Murali, M. Deepak and Amit Agarwal
Affiliation:
Keywords: Andrographis paniculata, leaves, non-leaves, inflammatory mediators (NO, IL-1 beta, IL-6, LTB4, PGE2, TNF-alpha and TXB2)
Abstract: This study was designed to evaluate and compare the inhibitory property of extracts of Andrographis paniculata leaves [methanolic (AP1), hydroalcoholic (AP2), successive water (AP3)] and non-leaves [methanolic (AP4), hydroalcoholic (AP5), successive water (AP6)] towards inflammatory mediators (NO, IL-1 beta, IL-6, TNF alpha, PGE2, TXB2 and LTB4). Stimulant induced J774A.1 murine macrophages and HL-60 promyelocytic leukemic cells were used to study the inhibitory potential of extracts of A. paniculata on inflammatory mediators. Results revealed that AP1 and AP4 exhibited inhibitory effect on all the inflammatory mediators excluding PGE2 and TNF-alpha. AP2 and AP5 exhibited inhibitory effect towards IL-1 beta, TXB2 and did not show inhibitory effect towards other mediators. However, AP3 and AP6 failed to show inhibitory activity against any of the inflammatory mediators at the tested concentrations. Further, we observed that the magnitude of inhibitory effect displayed by A. paniculata extracts depends on the andrographolide content, although, it does not appear to influence the inhibitory effect towards LTB4 production.
Export Options
About this article
Cite this article as:
V. Chandrasekaran C., Murali B., Deepak M. and Agarwal Amit, In Vitro Comparative Evaluation of Non-Leaves and Leaves Extracts of Andrographis paniculata on Modulation of Inflammatory Mediators, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012; 11 (2) . https://dx.doi.org/10.2174/187152312803305731
DOI https://dx.doi.org/10.2174/187152312803305731 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies
Current Clinical Pharmacology Editorial [Hot Topic: “Supramolecular Transmembrane Nanocarriers for Targeted Therapeutics” (Guest Editor: Grzegorz Bazylak) ]
Current Drug Discovery Technologies Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases
Current Pharmaceutical Design Therapeutic Potential of Inhibiting Brutons Tyrosine Kinase, (BTK)
Current Pharmaceutical Design The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design Mechanisms Underlying Chemopreventive Effects of Flavonoids via Multiple Signaling Nodes within Nrf2-ARE and AhR-XRE Gene Regulatory Networks
Current Chemical Biology Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders
Current Pharmaceutical Design Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease
Current Pharmaceutical Design Salusins in Hypertension and Related Cardiovascular Diseases
Current Drug Metabolism Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives
Current Medicinal Chemistry The Role of Immune and Inflammatory Mechanisms in ALS
Current Molecular Medicine Recent Developments of 2–Substituted Analogs of 1,25(OH)<sub>2</sub>D<sub>3</sub>
Current Medicinal Chemistry Oxidative Imbalance and Anxiety Disorders
Current Neuropharmacology Overview of Cantharidin and its Analogues
Current Medicinal Chemistry Novel Systemic Markers for Patients with Alzheimer Disease? – A Pilot Study
Current Alzheimer Research Indole-3-ethylsulfamoylphenylacrylamides with Potent Anti-proliferative and Anti-angiogenic Activities
Anti-Cancer Agents in Medicinal Chemistry Clinical and Radiological Characteristics of SAPHO Syndrome
Current Rheumatology Reviews Ascaris lumbricoides: An Overview of Therapeutic Targets
Infectious Disorders - Drug Targets Targeting the Multifaceted HuR Protein, Benefits and Caveats
Current Drug Targets Gene Therapy in the Transplantation of Allogeneic Organs and Stem Cells
Current Gene Therapy